$BLUE is slowly making progress again
CMS enters agreement with Vertex ($VRTX (-1,57 %) ), bluebird to improve access to gene therapies
$BLUE is slowly making progress again
CMS enters agreement with Vertex ($VRTX (-1,57 %) ), bluebird to improve access to gene therapies